News & Articles

Partnerships, products, and solutions facilitate detection, research, and vaccine development to combat the SARS-CoV-2 virus

The “triple antibody” test will provide health professionals with an accurate indication of the presence of IgA, IgM and IgG COVID-19 antibodies within 10 minutes

Establishing a broad range of remotely accessible COVID-19 assays including biochemical profiling for COVID-19 drug targets

Avacta to begin clinical validation of the high-throughput COVID-19 laboratory test in collaboration with the UK government CONDOR program

A new test being developed by Iceni Diagnostics promises a quick way to distinguish between the two diseases

Promega automated sample preparation solution added to CDC COVID-19 test protocol

The test is intended to expand availability of COVID-19 screening resources in central Ohio

Join us on Wednesday, August 5, to learn how in vitro models can enable a deeper understanding of T cell biology

Interim data shows strong antibody and T-cell responses in all evaluated participants

Cambridge researchers have shown how rapid genome sequencing of virus samples and enhanced testing of hospital staff can help to identify clusters of healthcare-associated COVID-19 infections

The bridging assay aims to allow a full-length trimeric Spike protein from the COVID-19 virus to be used as both a capture and detection tool

Delivers major improvements for discoveries in immunology, oncology, autoimmunity, and infectious diseases

Dr. Emma Walker reveals how transitioning from immunoassays to LC-MS/MS has helped deliver better diagnostic services in her lab

Partnership to evaluate the use of Affimer reagents to detect the coronavirus using novel sensors

Find out about the 'revolutionary' technology enabling one lab to provide higher-quality, more timely data for cancer researchers

Collaboration combines innovative plant-based and adjuvant technologies to develop and produce a COVID-19 candidate vaccine

The strategic partnership aims to catapult COVID-19 diagnostic testing capacity well ahead of the significant demand

Dr. Dennis Nurjadi discusses the cell counting technology that has brought his team accuracy and reproducibility

This is the company's third diagnostic test to receive Emergency Use Authorization by U.S. FDA for detecting COVID-19

Join us on Monday, July 20, to discover the benefits of in-solution equilibrium affinity experiments using Gyrolab systems